| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |